EX-99.3 4 g96654exv99w3.htm EX-99.3 2005 FINANCIAL GUIDANCE SUMMARY EX-99.3 2005 FINANCIAL GUIDANCE SUMMARY
 

Exhibit 99.3
2005 FINANCIAL GUIDANCE SUMMARY
(Table presented in thousands)
                   
                   
Consolidated   Range    
Revenues
  $ 1,260,000     $ 1,300,000    
 
             
Income before taxes, non-cash and other items
  $ 182,000     $ 202,000    
Depreciation and amortization
    69,000       73,000    
Non-cash advertising and distribution services and stock compensation
    13,000       15,000    
Other expense
    6,000       6,000    
Legal expense
    8,000       8,000    
Income tax provision
    13,000       15,000    
 
             
Net income
  $ 73,000     $ 85,000    
 
             
Background and Assumptions
    The 2005 guidance reflects the actual first and second quarter expenses for the on-going Department of Justice Investigation but does not include any projected expenses related to the Department of Justice Investigation, which may continue to be significant.
 
    The 2005 guidance includes the impact of our Healthshare acquisition from its acquisition date of March 14, 2005 but does not include the effects of any additional acquisitions that may occur during 2005.
 
    The 2005 guidance does not reflect the effect of the WebMD Health IPO, including incremental public company costs, the net proceeds of the IPO itself, shared services allocations between segments and the post-IPO minority interest.